Yong Ma

Title: Yong Ma: Innovator in RNA Interference Technology

Introduction

Yong Ma is a prominent inventor based in Daly City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of RNA interference. His work focuses on the modulation of gene expression, which has important implications for the diagnosis and treatment of various diseases.

Latest Patents

Yong Ma holds a patent for "RNA interference mediated inhibition of isocitrate dehydrogenase (IDH1) gene expression." This invention relates to compounds, compositions, and methods for studying, diagnosing, and treating traits, diseases, and conditions that respond to the modulation of IDH1 and mutant IDH1 gene expression. The patent specifically involves double-stranded nucleic acid molecules, including small nucleic acid molecules such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules. These molecules are capable of mediating RNA interference against IDH1 or mutant IDH1 gene expression.

Career Highlights

Yong Ma is currently associated with Sirna Therapeutics, Inc., where he continues to advance his research in RNA interference technology. His innovative work has positioned him as a key figure in the biotechnology sector.

Collaborations

Yong Ma has collaborated with notable colleagues, including Duncan F Brown and Steven Bartz. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Yong Ma's contributions to RNA interference technology exemplify the potential of innovative research in biotechnology. His patent on IDH1 gene expression modulation highlights the importance of his work in addressing critical health challenges.